Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata without access to the full warning letter, this FDA warning involves New Mexico Lions Eye Bank, a biologics manufacturer involved in eye tissue banking and conservation. The specific violations cannot be determined as the subject line is unavailable, though the warning likely pertains to manufacturing, processing, or quality control practices for human tissue products regulated as biologics. The warning was issued by the FDA in June 2024, indicating regulatory concerns with the company's operations that required formal corrective action notice.